![](/img/cover-not-exists.png)
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
Overman, Michael J, McDermott, Ray, Leach, Joseph L, Lonardi, Sara, Lenz, Heinz-Josef, Morse, Michael A, Desai, Jayesh, Hill, Andrew, Axelson, Michael, Moss, Rebecca A, Goldberg, Monica V, Cao, Z AlexLanguage:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(17)30422-9
Date:
July, 2017
File:
PDF, 437 KB
english, 2017